Results 31 to 40 of about 377 (154)
SLEEP MEDICINE: PRACTICE, CHALLENGES AND NEW FRONTIERS [PDF]
, 2022 Sleep medicine is an ambitious cross-disciplinary challenge, requiring the mutual integration between complementary specialists in order to build a solid framework.
Azzi, Nicoletta +4 more
core +5 more sources
Pharmacologic treatment of fibromyalgia: an update. [PDF]
Front PharmacolFibromyalgia (FM) is a chronic pain disorder characterized by widespread musculoskeletal pain, frequently accompanied by fatigue, sleep disturbances, cognitive dysfunction, and mood disorders.
Li Y +9 more
europepmc +3 more sources
A randomized study of solriamfetol for excessive sleepiness in narcolepsy [PDF]
, 2019 Objective: Solriamfetol (JZP-110) is a selective dopamine and norepinephrine reuptake inhibitor with wake-promoting effects. This phase 3 study (NCT02348593) evaluated the safety and efficacy of solriamfetol in narcolepsy.
Black J. +11 more
core +1 more source
Individualized Therapeutic Composition as a Method of Improving Sleep Quality in College Students [PDF]
, 2023 The life of a college student is often bombarded with circumstances, emotions, and decisions that produce stress and anxiety, affecting sleep quality and daily function.
Lanz, Nicholas
core +2 more sources
Sodium oxybate in narcolepsy with cataplexy: Zurich sleep center experience [PDF]
, 2011 Sodium oxybate (SO; Xyrem®) has been approved in most countries for treatment of narcolepsy and cataplexy. In this study, we present a single-center experience of a series of 18 patients with narcolepsy with cataplexy (18/18 DQB1*0602 positive, 17/17 ...
Bassetti, C L +7 more
core +1 more source
Narcolepsy is mainly associated with excessive daytime sleepiness, but the characteristic feature is abnormal rapid eye movement (REM) sleep phenomena.
Dauvilliers, Yves +2 more
core +1 more source
New developments in the management of narcolepsy [PDF]
, 2017 Narcolepsy is a life-long, underrecognized sleep disorder that affects 0.02%–0.18% of the US and Western European populations. Genetic predisposition is suspected because of narcolepsy’s strong association with HLA DQB1*06-02, and genome-wide association
Christian Guilleminault, Vivien Abad
core +2 more sources
Implication of the thalamus in sleep alterations observed in Alzheimer's disease
Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.Abstract Alzheimer's disease (AD), the most common neurodegenerative disorder, is frequently accompanied by sleep disturbances. Alterations of sleep, in both quality and quantity, contribute to the progression of AD neuropathology. The thalamus, through its diverse nuclei, plays a central role in sleep regulation and sleep‐dependent memory ...
Carla Burnet‐Merlin +2 more
wiley +1 more source
Narcolepsy: Pathophysiology, Diagnosis, Management, and Future Directions, a Narrative Review
Brain and Behavior, Volume 15, Issue 12, December 2025.This visual summary outlines the pathophysiology of narcolepsy, driven by hypocretin loss, and details its clinical diagnosis, current management strategies, and the shift toward future disease‐modifying therapies like orexin agonists and immunomodulation.
Natasha Elaine Hastings +12 more
wiley +1 more source
A Neurologist's Guide to REM Sleep Behavior Disorder [PDF]
, 2020 REM Sleep Behavior Disorder (RBD) is a chronic sleep condition characterized by dream enactment and loss of REM atonia. Individuals often present to clinic with complaints of injury to themselves or their bed-partner due to violent movements during sleep.
Jones, Matthew +4 more
core +2 more sources